Inovio Pharmaceuticals, Inc. dropped 21.96% in after-hours trading, following the announcement of a proposed public offering of common stock and accompanying warrants. The company intends to offer and sell shares of its common stock, which may have led to the significant decline in its stock price.
Comments
No comments yet